Related Experiment Video
Updated: Jun 23, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
Published on: July 3, 2020
Bayesian modeling of follow-up studies with missing data
James D Stamey1, B Nebiyou Bekele, Stephanie Powers
1Department of Statistical Science, Baylor University, Waco, TX, USA. James_Stamey@baylor.edu
Purpose:
The purpose of this study is to illustrate the impact of ignoring missing data in follow-up studies and to provide a hierarchical Bayesian approach to simultaneously estimate rates and missing data probabilities.
Methods:
To account for missing data in follow up studies, a hierarchical Bayesian procedure is proposed and investigated via simulation.
Results:
A simulation study demonstrates the impact of ignoring missing data on inferences in terms of bias and in ranking populations in terms of risk. An example of rates of disabilities for various German construction worker professions also illustrates the usefulness of the method.
Conclusions:
Use of a hierarchical Bayesian approach allows for flexible modeling of rates and data availability.
Related Concept Videos
Censoring Survival Data
Mechanistic Models: Compartment Models in Individual and Population Analysis
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Assumptions of Survival Analysis
Parametric Survival Analysis: Weibull and Exponential Methods
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
